NCT03070548View on ClinicalTrials.gov

A Study of Talazoparib in Patients With Advanced Solid Tumors

PHASE1CompletedINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

September 30, 2016

Primary Completion Date

June 30, 2017

Study Completion Date

June 30, 2017

Conditions
Advanced Solid Tumors
Interventions
DRUG

Talazoparib

1 mg of talazoparib containing100 μCi of 14C-radiolabeled talazoparib

Trial Locations (1)

1077

PRA Magyarorszag Kft, Fazis I-es Klinikai Farmakologiai Vizsgalohely, Budapest

Sponsors

Lead Sponsor

Pfizer

Collaborators (1)

Medivation, Inc.
All Listed Sponsors
collaborator

Medivation, Inc.

INDUSTRY

lead

Pfizer

INDUSTRY